The US Court of Appeals for the Federal Circuit yesterday upheld a district court ruling that invalidated a patent owned by Roche Molecular Systems, a division of Roche that makes equipment and reagents.
Tom Duley has joined Sidley Austin after spending nearly five years at King & Spalding.
North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware.
The IP concessions in the United States-Mexico-Canada Agreement are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association.
The US International Trade Commission has voted to begin an investigation into US medical device maker ResMed following a complaint from New Zealand-based rival Fisher & Paykel Healthcare.
US-based law firm O’Melveny has hired Hassen Sayeed as a partner in its IP and technology practice group in New York.
The Patent Trial and Appeal Board invalidated a patent owned by biotech company Biogen yesterday, handing a victory to South Korea-based Celltrion.
Janssen, a subsidiary of Johnson & Johnson, has entered into a licence and collaboration agreement with drug maker Arrowhead Pharmaceuticals.
The UK’s Medicines and Healthcare Products Regulatory Agency is seeking industry views on a no-deal Brexit scenario.
Boston Pharmaceuticals yesterday signed deals with GSK and Novartis, licensing eight drug candidates in total.